Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies

Schizophrenia Bulletin

Volumn 29, Issue 1, 2003, Pages 73-80

  Davis, Sonia M ^a,b   Koch, Gary G ^b   Davis, C E ^b   LaVange, Lisa M ^b,c  

^a IQVIA   (United States)

^b IL   (United States)

^c Inspire Pharmaceuticals   (United States)

Author keywords

Composite endpoint; Effectiveness; Electronic data capture; Multiple comparisons; Outcome driven re randomization; Treatment discontinuation

Indexed keywords

NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG RESEARCH; EVALUATION; HEALTH CARE COST; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; REVIEW; SAFETY; SCHIZOPHRENIA; STATISTICAL ANALYSIS; TIME;

EID: 0038448309     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006993     Document Type: Review

References (16)

1. Bauer, P. Multiple testing in clinical trials. Statistics in Medicine, 10:871-890, 1991.
2. Bombardier, C., and Maetzel, A. Pharmacoeconomic evaluation of new treatments: Efficacy versus effectiveness studies? Annals of the Rheumatic Diseases, 58(Suppl 1):82-85, 1999.
3. Diggle, P.J.; Liang, K.; and Zeger, S.L. Analysis of Longitudinal Data. New York, NY: Oxford University Press, 1994.
4. Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika, 75:800-802, 1988.
5. Kay, S.R.; Fiszbein, A.; and Opler, L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2):261-276, 1987.
6. Koch, G.G. Discussion for alpha calculus in clinical trials: Considerations and commentary for the new millennium. Statistics in Medicine, 19:781-784, 2000.
7. Koch, G.G.; Sen, P.K.; and Amara, I.A. Logrank scores, statistics, and tests. In: Johnson, N.L., and Kotz, S. Encyclopedia of Statistical Sciences. Vol. 5. New York, NY: John Wiley and Sons, 1985. pp. 136-142.
8. Lehmacher, W.; Wassmer, G.; and Reitmeir, P. Procedures for two-sample comparisons with multiple endpoints controlling the experiment wise error rate. Biometrics, 47:511-521, 1991.
9. Moye, L.A. Alpha calculus in clinical trials: Considerations and commentary for the new millennium. Statistics in Medicine, 19:767-779, 2000.
10. O'Brien, P.C. Procedures for comparing samples with multiple endpoints. Biometrics, 40:1079-1087, 1984.
11. Revicki, D.A., and Frank, L. Pharmacoeconomic evaluation in the real world: Effectiveness versus efficacy studies. PharmacoEconomics, 15(5):423-434, 1999.
12. Schneider, L.S.; Olin, J.T.; Doody, R.S.; Clarck, C.M.; Morris, J.C.; Reisberg, B.; Schmitt, F.A.; Frundman, M.; Thomas, R.G.; and Ferris, S.H. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders, 11(Suppl 2):S22-32, 1997.
13. Schneider, L.S.; Tariot, P.N.; Lyketsos, C.G.; Dagerman, K.S.; Davis, K.L.; Davis, S.; Hsiao, J.K.; Jeste, D.V.; Katz, I.R.; Olin, J.T.; Pollock, B.G.; Rabins, P.V.; Rosenheck, R.A.; Small, G.W.; Lebowitz, B.; and Lieberman, J.A. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journal of Geriatric Psychiatry, 9(4):346-360, 2001.
14. Stroup, T.S.; McEvoy, J.P.; Swartz, M.S.; Byerly, M.J.; Glick, I.D.; Canive, J.M.; McGee, M.F.; Simpson, G.M.; Stevens, M.C.; and Lieberman, J.A. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development. Schizophrenia Bulletin, 29(1):15-31, 2003.
15. Swartz, M.S.; Perkins, D.O.; Stroup, T.S.; McEvoy, J.P.; Nieri, J.M.; and Haak, D.C. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophrenia Bulletin, 29(1):33-43, 2003.
16. Westfall, P.H.; Tobias, R.D.; Wolfinger, R.D.; and Hochberg, Y. Multiple Comparisons and Multiple Tests Using the SAS System. Cary, NC: SAS Institute, 1999.